Hamilton Lane Files For $200M Initial Public Offering

Feb 3 2017 | 12:52am ET

Global alternative investment manager Hamilton Lane has filed an S-1 registration statement to go public, according to a statement Wednesday and documents filed with U.S. Securities & Exchange Commission.

Hamilton Lane will list its Class A common stock on NASDAQ under the symbol HLNE, according to the statement. The company hopes to raise approximately $200 million in the offering, which is being jointly run by J.P. Morgan and Morgan Stanley. Goldman Sachs will act as lead co-manager and Keefe, Bruyette & Woods and Wells Fargo Securities will act as co-managers, the statement said. 

Hamilton Lane had $40 billion of AUM and around $273 billion of assets under advisement as of Sept. 30, according to the SEC filing, and is going public in order to raise its profile and provide a way for equity owners in the business a way to manage their investment. 

Significant restricted stock grants will be given to employees as part of the offering, the company said, in order to align the interests of non-management employees with stockholders. 

Founded in 1991 and headquartered in Bala Cynwyd, PA, Hamilton Lane is an independent alternative investment management firm providing private markets solutions to sophisticated investors worldwide. It has more than $315 billion in total assets under management and supervision deployed across a range of private market strategies.


In Depth

AIMA: Smaller Firms Remain the Lifeblood of the Hedge Fund Industry

Jul 26 2017 | 5:55pm ET

It is a hedge fund industry truism that the largest managers receive the most attention...

Lifestyle

CFA Institute To Add Computer Science To Exam Curriculum

May 24 2017 | 9:25pm ET

Starting in 2019, financial industry executives sitting for the coveted Chartered...

Guest Contributor

Rastegar: PE Real Estate Gains Momentum as Uncertainty Rises

Jul 21 2017 | 6:04pm ET

The steady march of equity markets and fundamental shift in the direction of Fed...

 

From the current issue of